plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - Ónæmisörvandi, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
astrozol filmuhúðuð tafla 1 mg
williams & halls ehf - anastrozolum inn - filmuhúðuð tafla - 1 mg
sandimmun innrennslisþykkni, lausn 50 mg/ml
novartis healthcare a/s - ciclosporinum inn - innrennslisþykkni, lausn - 50 mg/ml
vigamox (moxifloxacin alcon) augndropar, lausn 5 mg/ml
novartis healthcare a/s - moxifloxacinum hýdróklóríð - augndropar, lausn - 5 mg/ml
metvix krem 160 mg/g
galderma nordic ab - methyl aminolevulinate hydrochloride - krem - 160 mg/g
ondansetron fresenius kabi stungulyf, lausn 2 mg/ml
fresenius kabi ab - ondansetronum hýdróklóríð - stungulyf, lausn - 2 mg/ml
eqvalan duo vet. pasta til inntöku
boehringer ingelheim animal health france scs - ivermectinum inn; praziquantelum inn - pasta til inntöku
morphasol vet stungulyf, lausn 4 mg/ml
animedica gmbh* - butorphanolum tartrat - stungulyf, lausn - 4 mg/ml
boostrix stungulyf, dreifa áfyllt sprauta
glaxosmithkline pharma a/s - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid - stungulyf, dreifa - áfyllt sprauta
boostrix polio stungulyf, dreifa áfyllt sprauta
glaxosmithkline pharma a/s - diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin; pertactin; poliovirus inactivated type 1; poliovirus inactivated type 2; poliovirus inactivated type 3 - stungulyf, dreifa - áfyllt sprauta